News & Updates

REL-1017 (esmethadone), a novel N-methyl-D-aspartate receptor channel blocker, demonstrates favourable safety, tolerability, and pharmacokinetic profiles and appears to have rapid and sustained antidepressant effects relative to placebo in major depressive disorder patients with inadequate responses to antidepressant treatments, according to a recent study.

Exposure to social unrest and the coronavirus disease 2019 (COVID-19) pandemic may increase depressive and post-traumatic stress disorder (PTSD) symptoms among women in Hong Kong, according to a study by the Queen Mary Hospital and University of Hong Kong (HKU).

Treatment with three infusions of ketamine is acceptable among patients with alcohol use disorder and results in more days of abstinence from alcohol at 6-month follow-up, a study has shown.

Acupuncture seems to be better than pharmacotherapy at relieving emotional symptoms in patients with functional gastrointestinal disorders (FGIDs), reports a recent meta-analysis.

People with moderate or severe depressive symptoms are more likely to endorse misinformation about coronavirus disease 2019 (COVID-19) vaccines, and those who embrace vaccine misinformation are half as likely to be vaccinated, a study in the US has shown.

In schizophrenia patients with related psychoses, physical aggression seems to be higher among men, those with lower education, and those diagnosed at an older age, according to a recent Singapore study.

Obsessive-compulsive symptoms appear to frequently occur among schizophrenic patients receiving treatment with clozapine, and these symptoms exert a negative effect on the patients’ wellbeing, a study reports.